The shikimate pathway is a sequence of enzyme-catalyzed reactions that produces chorismate, a major precursor of aromatic compounds in biological systems. Its canonical form converts phosphoenolpyruvate and erythrose 4-phosphate into chorismate through seven reactions. Present in plants, fungi, many bacteria, and numerous microbial eukaryotes, it connects central carbon metabolism with the synthesis of aromatic amino acids and a wide range of specialized metabolites. Animals lack the complete pathway, making it an important biochemical distinction between animals and many organisms on which they depend for nutrients.
Metabolic role and distribution
The pathway takes its name from shikimic acid, whose ionized form, shikimate, is an intermediate rather than the final product. Chorismate is the endpoint of the shared pathway and a branch point for several subsequent biosynthetic routes.
Its best-known products are phenylalanine, tyrosine, and tryptophan. These amino acids are incorporated into proteins, but also provide starting materials for numerous other compounds. In plants, phenylalanine feeds phenylpropanoid metabolism, which produces lignin, many pigments, and diverse compounds involved in defense and environmental responses. Tryptophan supplies precursors for indole-containing metabolites, including some routes of auxin biosynthesis.
Chorismate also supplies precursors for other important products. Depending on the organism, these include para-aminobenzoate for folate synthesis, intermediates for quinone biosynthesis, and compounds involved in iron acquisition. Not all organisms possess every downstream branch.
The pathway is widely distributed but not universal among microorganisms. Some species depend on environmental supplies of aromatic metabolites and lack part or all of the biosynthetic machinery. Many archaea make chorismate through routes with alternative early reactions rather than the complete canonical seven-step sequence. Consequently, the ability to synthesize chorismate should not automatically be equated with possession of every enzyme in the standard pathway.
Precursors and the seven reactions
The canonical pathway combines two intermediates of central carbon metabolism:
- Phosphoenolpyruvate (PEP), a three-carbon compound associated with glycolysis.
- Erythrose 4-phosphate (E4P), a four-carbon intermediate of the pentose phosphate pathway.
One PEP molecule and one E4P molecule provide the seven-carbon framework of the early intermediates. A second PEP molecule is incorporated later, producing the ten-carbon framework of chorismate.
| Step | Enzyme | Main transformation |
|---|---|---|
| 1 | 3-Deoxy-D-arabino-heptulosonate 7-phosphate synthase, usually abbreviated DAHP synthase | Condenses PEP and E4P to form DAHP, releasing inorganic phosphate. |
| 2 | 3-Dehydroquinate synthase | Converts DAHP into the cyclic compound 3-dehydroquinate. |
| 3 | 3-Dehydroquinate dehydratase | Removes water from 3-dehydroquinate to form 3-dehydroshikimate. |
| 4 | Shikimate dehydrogenase | Reduces 3-dehydroshikimate to shikimate, usually using NADPH. |
| 5 | Shikimate kinase | Uses [[adenosine-triphosphate |
| 6 | 5-Enolpyruvylshikimate-3-phosphate synthase, abbreviated EPSP synthase or EPSPS | Transfers an enolpyruvyl group from a second PEP molecule to shikimate 3-phosphate, releasing inorganic phosphate. |
| 7 | Chorismate synthase | Converts EPSP into chorismate through elimination of phosphate. |
This sequence requires carbon precursors, reducing power, and ATP. Their availability influences how much material can pass through the pathway, although control is distributed among precursor supply, enzyme activity, and downstream demand.
Mechanistic features
Several steps involve chemistry more elaborate than their short names suggest. Dehydroquinate synthase performs a multistage transformation involving oxidation, phosphate elimination, reduction, ring opening, and ring closure. Its bound NAD cofactor is regenerated during the catalytic cycle rather than consumed as a net oxidant.
Dehydroquinate dehydratases occur in two major types with distinct structures and catalytic mechanisms. They catalyze the same overall reaction but are not simply interchangeable versions of one protein architecture.
Chorismate synthase requires reduced flavin mononucleotide as a cofactor, even though the overall conversion of EPSP to chorismate is not a net oxidation–reduction reaction. This requirement illustrates the distinction between a cofactor’s participation in a reaction mechanism and the net chemical balance of that reaction.
Branches downstream of chorismate
The shikimate pathway is sometimes described loosely as the pathway of aromatic amino acid biosynthesis. More precisely, it is the shared upstream route; the reactions after chorismate differ among the products and among organisms.
Phenylalanine and tyrosine
Chorismate mutase rearranges chorismate to prephenate. From prephenate, different combinations of transamination, dehydration, oxidative decarboxylation, and other reactions lead to phenylalanine and tyrosine.
Two common arrangements involve either arogenate or the corresponding aromatic keto acids. The arogenate routes are especially important in plants, whereas the distribution of routes among microorganisms varies. Some organisms also produce tyrosine from phenylalanine through a separate hydroxylation reaction.
Tryptophan
Anthranilate synthase directs chorismate toward anthranilate, the first committed intermediate in the usual tryptophan biosynthetic branch. Further reactions construct the indole ring and complete tryptophan formation.
Other aromatic products
Other branches use chorismate to form para-aminobenzoate, isochorismate, or hydroxybenzoates. These intermediates contribute to folates, certain respiratory quinones, and some iron-binding compounds. In plants, chorismate also supports salicylic acid biosynthesis through an isochorismate-associated route.
These branches help explain why blocking the shikimate pathway can affect more than protein synthesis: it may simultaneously restrict several classes of metabolites.
Cellular organization and regulation
Compartmentation and enzyme organization
In plants, the canonical pathway operates predominantly in plastids, including chloroplasts. Most of its enzymes are encoded by nuclear genes and imported into plastids. Exchange of precursors and products between cellular compartments therefore contributes to overall pathway function.
In many bacteria, the seven activities are carried by separate proteins. In many fungi, five consecutive activities—from dehydroquinate synthase through EPSP synthase—are combined in a large multifunctional protein commonly called AROM. Such fusions bring several catalytic domains into one polypeptide, but their presence alone does not establish that intermediates are transferred directly between active sites without entering the surrounding solution.
Regulation of pathway flow
Entry into the pathway is frequently regulated at DAHP synthase. In Escherichia coli, three DAHP synthase isoenzymes are preferentially feedback-inhibited by phenylalanine, tyrosine, and tryptophan, respectively. This arrangement links pathway input to the availability of its principal amino acid products.
Regulation differs substantially across organisms. It can involve:
- Feedback inhibition by end products.
- Changes in gene expression.
- Regulation at downstream branch points.
- Supply of PEP, E4P, ATP, and reducing equivalents.
- Transport between compartments or across the cell membrane.
An enzyme that strongly controls pathway flow under one growth condition may exert less control under another. Increasing the abundance of a single enzyme therefore does not necessarily increase final product yield.
Glyphosate and pathway inhibition
The herbicide glyphosate inhibits EPSP synthase. It binds strongly to the enzyme–shikimate 3-phosphate complex and interferes with the productive binding of PEP. In susceptible plants, inhibition restricts chorismate formation and downstream metabolism; shikimate accumulation is a characteristic biochemical response.
The absence of EPSP synthase from animals explains the selectivity of this molecular target, but does not by itself establish the safety of a substance or formulation under every exposure condition. Target distribution, exposure, formulation, and effects on other organisms are separate questions.
Glyphosate resistance can arise through several mechanisms, including changes in EPSP synthase, increased production of the enzyme, and reduced movement of the herbicide to sensitive tissues. Some engineered crops express an EPSP synthase with reduced sensitivity to glyphosate. Naturally occurring enzyme variants also differ in sensitivity.
Other shikimate-pathway enzymes have been investigated as antimicrobial targets. Absence of the pathway in animals provides a rationale for such research, but enzyme inhibition alone does not demonstrate effectiveness against an infection. Uptake, metabolic bypass, nutrient availability, and resistance can all affect the biological outcome.
Biotechnology and research
The pathway is an important target in biotechnology because it channels carbohydrate-derived carbon into valuable aromatic compounds. Engineered microbial strains can produce shikimate, aromatic amino acids, and various downstream chemicals.
Common engineering strategies include increasing precursor supply, reducing feedback inhibition, modifying competing reactions, and improving product export. Restricting a downstream reaction can cause an intermediate such as shikimate to accumulate, but excessive restriction may also limit growth by reducing the supply of essential products. Product formation and cellular growth must therefore be considered together.
Shikimic acid is also used as a chemical starting material in pharmaceutical manufacturing, notably in routes for producing oseltamivir. This industrial role is distinct from the biological function of the pathway and does not imply that shikimic acid itself has the same pharmacological activity.
Historical development
Shikimic acid was first isolated in the nineteenth century from Japanese star anise. Its role in metabolism was established much later, particularly through mid-twentieth-century studies of microbial nutritional mutants and labeled precursors.
Mutants blocked at different biosynthetic steps accumulated different intermediates or required particular nutrients for growth. Combining these observations with biochemical experiments helped establish the order of reactions and the shared origin of the aromatic amino acids. Subsequent enzymology, genetics, and structural studies clarified the catalytic mechanisms, regulatory systems, and organism-specific variations of the pathway.